-
Nasal bone in first-trimester screening for trisomy 21.
Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH.
Am J Obstet Gynecol 2006;195:109-14. -
Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study.
Chitty LS, Kagan KO, Molina FS, Waters JJ, Nicolaides KH.
BMJ 2006;332:452-5. -
Aneuploidy screening in a coelomic sample from a missed abortion using sequential fluorescence in situ hybridization.
Chatzimeletiou K, Makrydimas G, Nicolaides KH.
Fertil Steril 2006;85:1059. -
Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis.
Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM.
Clin Chem 2006;52:2211-8. -
Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M, Dagklis T, Csapo B, Sotiriadis A, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;28:870-5. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery.
To MS, Skentou C, Liao AW, Cacho A, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:200-3. -
Outcome for children born after in utero laser ablation therapy for severe twin-to-twin transfusion syndrome.
Sutcliffe AG, Sebire NJ, Pigott AJ, Taylor B, Edwards PR, Nicolaides KH.
BJOG 2001;108:1246-50. -
Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use?
Surbek DV, Holzgreve W, Nicolaides KH.
Hum Reprod Update 2001;7:85-91. -
First trimester maternal serum placenta growth factor (PlGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18.
Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH.
Prenat Diagn 2001;21:718-22. -
Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks.
Spencer K, Liao AW, Ong CY, Flack NJ, Nicolaides KH.
Prenat Diagn 2001;21:571-4. -
Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH.
Prenat Diagn 2001;21:441-4. -
Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies.
Spencer K, Liao AW, Skentou H, Ong CY, Nicolaides KH.
Prenat Diagn 2001;21:270-3. -
Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.
Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:9-17. -
Prediction of preterm delivery in twins by cervical assessment at 23 weeks.
Skentou C, Souka AP, To MS, Liao AW, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;17:7-10. -
Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.
Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD.
Hypertension 2001;38:1289-93. -
Twin chorionicity and pre-eclampsia.
Savvidou MD, Karanastasi E, Skentou C, Geerts L, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:228-31. -
Assessment of endothelial function in normal twin pregnancy.
Savvidou MD, Donald AE, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;17:220-3. -
Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts.
Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J.
Anat Embryol 2001;204:399-406. -
Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound.
Paul C, Krampl E, Skentou C, Jurkovic D, Nicolaides KH.
Ultrasound Obstet Gynecol 2001;18:481-4.